Aurobindo Pharma USA is voluntarily recalling blood pressure pills because of contaminants that may cause cancer.
FDA announces that the Quinapril blood pressure medicine recalls for contaminants that may cause cancer.
The Quinapril And Hydrochlorothiazide Tablets
The recalled tablets may contain nitrosamine, a compound that’s associated with an increased cancer risk according to the U.S. Food and Drug Administration (FDA). The Aurobindo Pharma USA is recalling two lots of its quinapril and hydrochlorothiazide tablets, which are prescribed to lower blood pressure in people with hypertension, over concerns that the pills may be contaminated with nitrosamine, the FDA said in a statement.
Natural sources of nitrosamines include a wide range of vegetables, dairy products, and cured or grilled meats. FDA prolonged exposure to nitroamine at high concentrations can raise the chance of developing cancer.
the FDA said that the expiry dates for both batches of the recalled blood pressure medication were in January 2023. The pills are described as being “pink colored, scored, round, biconvex, film-coated tablets, debossed with ‘D’ on the scored side and ‘19’ on the other side.”
The Recalled Tablets
The recalled pills contain a combination of two drugs: quinapril hydrochloride, in a family of medicines known as angiotensin-converting enzyme (ACE) restraint that lower blood pressure by relaxing blood vessels; and hydrochlorothiazide, in a family of medicines known as diuretics that cope blood pressure by reducing fluid retention.
Some patients may be able to switch to a treatment regimen of two separate tablets — one for each of the medicines contained in the recalled pills.
